HIV screening most optimal at 25 years of age if no risk factors

January 9, 2018

(HealthDay)—For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective, according to a study published in the January issue of the Journal of Adolescent Health.

Anne M. Neilan, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues simulated HIV-uninfected 12-year-olds without identified who faced age-specific HIV infection risks. The authors modeled a one-time HIV screen ($36) at age 15, 18, 21, 25, or 30 years, each in addition to current U.S. screening practices (30 percent screened by age 24).

The researchers found that all one-time screens detected a small proportion of lifetime infections (0.1 to 10.3 percent). A screen at 25 years led to the most favorable care continuum outcomes at age 25 compared to current , with a higher proportion diagnosed (77 versus 51 percent), linked to care (71 versus 51 percent), retained in care (68 versus 44 percent), and virologically suppressed (49 versus 32 percent). A screen at age 25 years not only provided the greatest clinical benefit but also was cost-effective ($96,000/year-of-life saved [YLS]) by U.S. standards of <$100,000/YLS compared with the next most effective screen.

"Focusing screening on adolescents and young adults ages 18 or younger is a less efficient use of a one-time screen among AYA than screening at a later age," the authors write.

Explore further: New evidence supports HIV screening in young adulthood

More information: Abstract/Full Text

Related Stories

New evidence supports HIV screening in young adulthood

December 19, 2017
A new study suggests that the most beneficial age for a one-time screening HIV test of the general population would be age 25. The report - led by researchers at Massachusetts General Hospital (MGH) working with the U.S. ...

Findings could help reduce risk of calciphylaxis in renal disease

December 14, 2017
(HealthDay)—For patients with late-stage renal disease, the presence of lupus anticoagulant and combined thrombophilias are risk factors for the development of calciphylaxis, according to a study published online Dec. 13 ...

STEMI patient perceptions impact emergency medical services use

December 19, 2017
(HealthDay)—ST-elevation myocardial infarction (STEMI) patient perceptions, including those involving the speed of transport and concerns about resource misuse, are an important factor in determining emergency medical services ...

Analysis of EBV DNA in plasma samples IDs nasopharyngeal CA

August 10, 2017
(HealthDay)—Analysis of Epstein-Barr virus (EBV) DNA in plasma samples can identify early asymptomatic nasopharyngeal carcinoma, according to a study published in the Aug. 10 issue of the New England Journal of Medicine.

Worse HIV care outcomes for Hispanics, Latinos

October 16, 2017
(HealthDay)—HIV care outcomes are worse for Hispanics and Latinos, especially for injection drug users, according to a study published online Oct. 12 in Morbidity and Mortality Weekly Report.

Bone strength + bone mineral density screening cost-effective

October 29, 2017
(HealthDay)—Combined assessment of bone strength and bone mineral density is a cost-effective strategy for osteoporosis screening in postmenopausal women, according to a study published in the November issue of Radiology.

Recommended for you

Study shows how HIV is shielded from immune attack

July 10, 2018
Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.

Out-of-pocket costs put HIV prevention drug out of reach for many at risk

July 4, 2018
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks—the drug's price tag, which ...

New simulation tool predicts how well HIV-prophylaxis will work

June 14, 2018
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal ...

Many at risk for HIV despite lifesaving pill

June 11, 2018
Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

Active HIV in large white blood cells may drive cognitive impairment in infected mice

June 7, 2018
Macrophages, large white blood cells that engulf and destroy potential pathogens, harbor active viral reserves that appear to play a key role in impaired learning and memory in mice infected with a rodent version of HIV. ...

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains

June 4, 2018
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.